EVOTAZ is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Atazanavir Sulfate; Cobicistat.
| Product ID | 50090-1724_126b39ae-83bc-4de8-95e3-2f6e33291f19 | 
| NDC | 50090-1724 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | EVOTAZ | 
| Generic Name | Atazanavir And Cobicistat | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-01-29 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206353 | 
| Labeler Name | A-S Medication Solutions | 
| Substance Name | ATAZANAVIR SULFATE; COBICISTAT | 
| Active Ingredient Strength | 300 mg/1; mg/1 | 
| Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2015-03-04 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206353 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-03-04 | 
| Marketing End Date | 2018-03-31 | 
| Ingredient | Strength | 
|---|---|
| ATAZANAVIR SULFATE | 300 mg/1 | 
| SPL SET ID: | a2d380fa-9413-47f5-8e5a-8163ae55e6e7 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | 
| 50090-1724 | EVOTAZ | atazanavir and cobicistat | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  EVOTAZ  86092023  4765196 Live/Registered | Bristol-Myers Squibb Company 2013-10-15 |